Email This Article

FDA's Serono Approval Starts the MS Drug Wars Early
By Adam Feuerstein
03/08/02 - 11:44 AM EST
Until Rebif was approved, Biogen had orphan drug status for Avonex through next spring.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,405.83 1,102.35 2,190.86 34.82
Oil *
71.98
UP
68.78
UP
6.41
UP
7.13
UP
0.59
10 Yr
3.48%
SPDR Gold
110.82
+0.67%
+0.58%
+0.33%
+1.72%
Data delayed 20 minutes

Brokerage Partners